VISUOSPATIAL DEFICIT

VISUOSPATIAL DEFICIT was reported 91 times

VISUOSPATIAL DEFICIT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 1 0.0005
1 Glucosylceramide Synthase Inhibitor [EPC] 1 0.0004
2 Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] 1 0.0003
3 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 2 0.0003
4 Vitamin K [EPC] 2 0.0002
5 Dopamine-2 Receptor Antagonist [EPC] 1 0.0001
6 Orexin Receptor Antagonist [EPC] 2 0.0001
7 Sphingosine 1-phosphate Receptor Modulator [EPC] 1 0.0001
8 Cholinesterase Inhibitor [EPC] 1 0.0001
9 Human Immunoglobulin G [EPC] 1 0.0000
10 Anti-epileptic Agent [EPC] 9 0.0000
11 Central alpha-2 Adrenergic Agonist [EPC] 2 0.0000
12 Mood Stabilizer [EPC] 8 0.0000
13 Vitamin D [EPC] 11 0.0000
14 Vitamin B12 [EPC] 11 0.0000
15 Provitamin D2 Compound [EPC] 1 0.0000
16 Atypical Antipsychotic [EPC] 12 0.0000
17 Vitamin C [EPC] 11 0.0000
18 beta3-Adrenergic Agonist [EPC] 1 0.0000
19 Ester Local Anesthetic [EPC] 1 0.0000
20 Nitroimidazole Antimicrobial [EPC] 1 0.0000
21 Tetracycline-class Drug [EPC] 1 0.0000
22 Topoisomerase Inhibitor [EPC] 1 0.0000
23 Non-Standardized Chemical Allergen [EPC] 1 0.0000
24 Amide Local Anesthetic [EPC] 1 0.0000
25 Central Nervous System Stimulant [EPC] 1 0.0000
26 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
27 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
28 Estrogen [EPC] 2 0.0000
29 Benzodiazepine [EPC] 7 0.0000
30 Acetylcholine Release Inhibitor [EPC] 1 0.0000
31 Antiarrhythmic [EPC] 1 0.0000
32 Aminosalicylate [EPC] 1 0.0000
33 5-alpha Reductase Inhibitor [EPC] 1 0.0000
34 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
35 Factor Xa Inhibitor [EPC] 2 0.0000
36 Janus Kinase Inhibitor [EPC] 1 0.0000
37 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
38 Alkylating Drug [EPC] 1 0.0000
39 Platinum-based Drug [EPC] 1 0.0000
40 beta-Adrenergic Blocker [EPC] 1 0.0000
41 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
42 Corticosteroid [EPC] 3 0.0000
43 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
44 GLP-1 Receptor Agonist [EPC] 1 0.0000
45 Platelet Aggregation Inhibitor [EPC] 1 0.0000